跳至主要内容
临床试验/CTRI/2020/06/025918
CTRI/2020/06/025918招募中4 期

Dehydroepiandrosterone ( DHEA) role in enhancement and maintenance of implantation (DREAM) - Randomized Double Blind Placebo Controlled Trial - DREAM TRIA

CRAFT Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • INCLUSION CRITERIA
  • 1.Women with age more than or equal to 35 years Or
  • 2.women with AMH value less than 1.1 ng/ml or AFC less than 5 to 7
  • Whose serum testosterone less than 0.2 ng/ml

排除标准

  • EXCLUSION CRITERIA
  • Women with PCOS.
  • Women with serum Testosterone ââ?°Â¥0.2 ng/ml
  • women with BMI more than 30kg/mt2
  • Women with Congenital and untreated or acquired uterine abnormality.
  • Women with Untreated hydrosalpinx.
  • Women with Thrombophilia.
  • Women with uncontrolled endocrine and heamatological dysfunction.
  • PGTA embryos
  • Those planning embryo transfer as per endometrial receptivity ERA
  • Thin endometrium less than 8mm in index cycle.
  • severe male factor infertility.
  • Difficult embryo transfer.
  • Cases where only poor quality embryos are available.
  • Couple with genetic and chromosomal abnormality

研究者

发起方
CRAFT Hospital and Research Centre

相似试验